Home > Press > CRIXlabs promo presentation of NuSilico software created by Nanobotmodels: Nanobotmodels animation studio presents new CRIXlabs presentations about NuSilico software!
Abstract:
Pharmaceutical companies are investigating new methods of delivering drugs that spare healthy cells and focus only on killing cancer cells. They spend 135 billion dollars a year just on R and D. The slow progress is due to the time and effort it takes to get an answer. This mean that better cancer drug is decades away instead of a few years away.
Nanotechnology is the most promising technology to spare healthy cells for reduced side effects. And yet, this research is moving slowly due to the sheer time and money needed to complete experiments. One solution is software.
Researchers have been trying to find a software solution for some time now, but their approach has been to tackle modeling the entire body; nearly impossible to accurately complete do to the shear number of assumed, non-testable parameters and thousands of unique equations needed to produce an answer.
CRIXlabs engineers approached this problem by going through countless experiments looking into the chemistry and physical nature of drugs and where they end up in the body. We then organized this data based on the way experiments were conducted and their comparison with similar data.
The researcher followed the CRIXlabs systematic approach to building nanoparticles and together with the NuSilico simulations was able to pick the right nanoparticle to start with, necessary size, shape, and surface charge within the abilities of her lab.
Nanobotmodels animation studio in collaboration with CRIXlabs have created artistic presentations of the NuSilico software.
####
About Nanobotmodels Company
Nanobotmodels (www.nanobotmodels.com) was established in 2007 with the goal of developing highly innovative, digital graphics to depict actual and conceptual technologies via the synergistic fusion of art and science. The still nascent, yet prospectively powerful discipline of nanotechnology is poised to radically transform medicine, engineering, biotechnology, electronics and myriad other sectors in the relative near-term. Hence, visionary artistic renderings that portray various aspects of this exciting nanofuture will be beneficial in facilitating a clear understanding of its fundamental concepts to a broad demographic.
Nanobotmodels generates imaginative and engaging state-of-the-art nanotechnology and nanomedical illustrations and animations. Any prototypical component, device, system or far flung concept that might be conceived of can be translated into captivating and colorful photorealistic animated or static renderings and presentation materials…. We bring them all to life for you!
More information you can find here: www.nanobotmodels.com/node/99
About CRIXlabs
CRIXlabs, Inc. (www.crixlabs.com) is a life science software company, which predicts outcomes for biodistribution and half-life for a wide range of nanotherapeutics. Our NuSilico software has the ability to aid researchers in optimizing key characteristics to ensure their particles have a greater chance of reaching their targets. The CRIXlabs team brings expertise in software, nanotechnology, materials, product development, business development, and commercialization.
For more information, please click here
Contacts:
Svidinenko Yuriy CEO,
Nanobotmodels Company,
+380964704166 tel
Copyright © Nanobotmodels Company
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Videos/Movies
New X-ray imaging technique to study the transient phases of quantum materials December 29th, 2022
Solvent study solves solar cell durability puzzle: Rice-led project could make perovskite cells ready for prime time September 23rd, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Visualizing the invisible: New fluorescent DNA label reveals nanoscopic cancer features March 4th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||